Các Dấu Hiệu Bệnh Sinh Học Cho Thấy SARS-CoV-2 Mới Nổi Có Thể Tăng Cường Độ Nhạy Cảm Đối Với Sự Thoái Hóa Thần Kinh

Nicola M, Alsafi Z, Sohrabi C, Kerwan A, Al-Jabir A, Iosifidis C, Agha M, Agha R (2020) The socio-economic implications of the coronavirus pandemic (COVID-19): a review. Int J Surg 78:185–193. https://doi.org/10.1016/j.ijsu.2020.04.018 Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C et al (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 77(6):683–690. https://doi.org/10.1001/jamaneurol.2020.1127 Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, Collange O, Boulay C et al (2020) Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 382(23):2268–2270. https://doi.org/10.1056/NEJMc2008597 Montalvan V, Lee J, Bueso T, De Toledo J, Rivas K (2020) Neurological manifestations of COVID-19 and other coronavirus infections: a systematic review. Clin Neurol Neurosurg 194:105921. https://doi.org/10.1016/j.clineuro.2020.105921 Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, Kneen R, Defres S et al Neurological associations of COVID-19. Lancet Neurol. https://doi.org/10.1016/S1474-4422(20)30221-0 Coolen T, Lolli V, Sadeghi N, Rovaï A, Trotta N, Taccone FS, Creteur J, Henrard S et al (2020) Early postmortem brain MRI findings in COVID-19 non-survivors. Neurology. https://doi.org/10.1212/wnl.0000000000010116 Chougar L, Shor N, Weiss N, Galanaud D, Leclercq D, Mathon B, Belkacem S, Stroër S et al (2020) Retrospective observational study of brain magnetic resonance imaging findings in patients with acute SARS-CoV-2 infection and neurological manifestations. Radiology 2020:202422. https://doi.org/10.1148/radiol.2020202422 Gandhi S, Srivastava AK, Ray U, Tripathi PP (2020) Is the collapse of the respiratory center in the brain responsible for respiratory breakdown in COVID-19 patients? ACS Chem Neurosci 11(10):1379–1381. https://doi.org/10.1021/acschemneuro.0c00217 Nouri-Vaskeh M, Sharifi A, Khalili N, Zand R, Sharifi A (2020) Dyspneic and non-dyspneic (silent) hypoxemia in COVID-19: possible neurological mechanism. Clin Neurol Neurosurg 198:106217. https://doi.org/10.1016/j.clineuro.2020.106217 Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, Franciotta D, Baldanti F et al (2020) Guillain–Barré syndrome associated with SARS-CoV-2. N Engl J Med 382(26):2574–2576. https://doi.org/10.1056/NEJMc2009191 Arbour N, Côté G, Lachance C, Tardieu M, Cashman NR, Talbot PJ (1999) Acute and persistent infection of human neural cell lines by human coronavirus OC43. J Virol 73(4):3338–3350. https://doi.org/10.1128/jvi.73.4.3338-3350.1999 Yang AC, Kern F, Losada PM, Maat CA, Schmartz G, Fehlmann T, Schaum N, Lee DP, Calcuttawala K, Vest RT, Gate D, Berdnik D, McNerney MW, Channappa D, Cobos I, Ludwig N, Schulz-Schaeffer WJ, Keller A, Wyss-Coray T (2020) Broad transcriptional dysregulation of brain and choroid plexus cell types with COVID-19. bioRxiv:2020.2010.2022.349415. doi:https://doi.org/10.1101/2020.10.22.349415 Dorsey ER, Elbaz A, Nichols E, Abd-Allah F, Abdelalim A, Adsuar JC, Ansha MG, Brayne C et al (2018) Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17(11):939–953. https://doi.org/10.1016/S1474-4422(18)30295-3 Nichols E, Szoeke CEI, Vollset SE, Abbasi N, Abd-Allah F, Abdela J, Aichour MTE, Akinyemi RO et al (2019) Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18(1):88–106. https://doi.org/10.1016/S1474-4422(18)30403-4 Castillo X, Castro-Obregón S, Gutiérrez-Becker B, Gutiérrez-Ospina G, Karalis N, Khalil AA, Lopez-Noguerola JS, Rodríguez LL et al (2019) Re-thinking the etiological framework of neurodegeneration. Front Neurosci 13:728. https://doi.org/10.3389/fnins.2019.00728 Gitler AD, Dhillon P, Shorter J (2017) Neurodegenerative disease: models, mechanisms, and a new hope. Disease Models &amp. Mechanisms 10(5):499–502. https://doi.org/10.1242/dmm.030205 Kim JE, Heo JH, Kim HO, Song SH, Park SS, Park TH, Ahn JY, Kim MK et al (2017) Neurological complications during treatment of Middle East respiratory syndrome. J Clin Neurol 13(3):227–233. https://doi.org/10.3988/jcn.2017.13.3.227 Cheyette SR, Cummings JL (1995) Encephalitis lethargica: lessons for contemporary neuropsychiatry. J Neuropsychiatr Clin Neurosci 7(2):125–134. https://doi.org/10.1176/jnp.7.2.125 Giordano A, Schwarz G, Cacciaguerra L, Esposito F, Filippi M (2020) COVID-19: can we learn from encephalitis lethargica? Lancet Neurol 19(7):570. https://doi.org/10.1016/s1474-4422(20)30189-7 Hosseini S, Wilk E, Michaelsen-Preusse K, Gerhauser I, Baumgärtner W, Geffers R, Schughart K, Korte M (2018) Long-term neuroinflammation induced by influenza A virus infection and the impact on hippocampal neuron morphology and function. J Neurosci 38(12):3060–3080. https://doi.org/10.1523/jneurosci.1740-17.2018 Sy M, Kitazawa M, Medeiros R, Whitman L, Cheng D, Lane TE, Laferla FM (2011) Inflammation induced by infection potentiates tau pathological features in transgenic mice. Am J Pathol 178(6):2811–2822. https://doi.org/10.1016/j.ajpath.2011.02.012 Serrano-Castro PJ, Estivill-Torrús G, Cabezudo-García P, Reyes-Bueno JA, Ciano Petersen N, Aguilar-Castillo MJ, Suárez-Pérez J, Jiménez-Hernández MD et al (2020) Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic? Neurología (English Edition) 35(4):245–251. https://doi.org/10.1016/j.nrleng.2020.04.002 Louveau A, Herz J, Alme MN, Salvador AF, Dong MQ, Viar KE, Herod SG, Knopp J et al (2018) CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature. Nat Neurosci 21(10):1380–1391. https://doi.org/10.1038/s41593-018-0227-9 Silva MME, Mercer PBS, Witt MCZ, Pessoa RR (2018) Olfactory dysfunction in Alzheimer’s disease systematic review and meta-analysis. Dement Neuropsychol 12(2):123–132. https://doi.org/10.1590/1980-57642018dn12-020004 Lee J, Nallani R, Cass L, Bhalla V, Chiu A, Villwock J (2020) A systematic review of the neuropathologic findings of post-viral olfactory dysfunction: implications and novel insight for the COVID-19 pandemic. Am J Rhinol Allergy 1945892420957853. doi:https://doi.org/10.1177/1945892420957853 Guo A-X, Cui J-J, OuYang Q-Y, He L, Guo C-X, Yin J-Y (2020) The clinical characteristics and mortal causes analysis of COVID-19 death patients. medRxiv:2020.2004.2012.20062380. doi:https://doi.org/10.1101/2020.04.12.20062380 Qi J, Zhou Y, Hua J, Zhang L, Bian J, Liu B, Zhao Z, Jin S (2020) The scRNA-seq expression profiling of the receptor ACE2 and the cellular protease TMPRSS2 reveals human organs susceptible to COVID-19 infection. bioRxiv. https://doi.org/10.1101/2020.04.16.045690 Brann D, Tsukahara T, Weinreb C, Lipovsek M, Van den Berge K, Gong B, Chance R, Macaulay I et al (2020) Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. bioRxiv. https://doi.org/10.1101/2020.03.25.009084 Bagasra O, Pandey P, McCean E, Albrecht H Infectivity of human olfactory neurons to SARS-CoV-2: a link to anosmia. Zapiec B, Dieriks BV, Tan S, Faull RLM, Mombaerts P, Curtis MA (2017) A ventral glomerular deficit in Parkinson’s disease revealed by whole olfactory bulb reconstruction. Brain 140(10):2722–2736. https://doi.org/10.1093/brain/awx208 Sanjari Moghaddam H, Dolatshahi M, Salardini E, Aarabi MH (2019) Association of olfaction dysfunction with brain microstructure in prodromal Parkinson disease. Neurol Sci 40(2):283–291. https://doi.org/10.1007/s10072-018-3629-2 Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395(10229):1033–1034. https://doi.org/10.1016/s0140-6736(20)30628-0 Mohammadi S, Moosaie F, Aarabi MH (2020) Understanding the immunologic characteristics of neurologic manifestations of SARS-CoV-2 and potential immunological mechanisms. Mol Neurobiol 57(12):5263–5275. https://doi.org/10.1007/s12035-020-02094-y Ng A, Tam WW, Zhang MW, Ho CS, Husain SF, McIntyre RS, Ho RC (2018) IL-1β, IL-6, TNF-α and CRP in elderly patients with depression or Alzheimer’s disease: systematic review and meta-analysis. Sci Rep 8(1):12050. https://doi.org/10.1038/s41598-018-30487-6 Naughton SX, Raval U, Pasinetti GM (2020) Potential novel role of COVID-19 in Alzheimer’s disease and preventative mitigation strategies. J Alzheimers Dis 76:21–25. https://doi.org/10.3233/JAD-200537 Siu K-L, Yuen K-S, Castano-Rodriguez C, Ye Z-W, Yeung M-L, Fung S-Y, Yuan S, Chan C-P et al (2019) Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC. FASEB J 33(8):8865–8877. https://doi.org/10.1096/fj.201802418R Tuma R, Guedes B, Carra R, Iepsen B, Rodrigues J, Camelo Filho AE, Kubota G, Ferrari M, Studart-Neto A, Oku M, Terrim S, Lopes C, Passos Neto CE, Dalben M, De Souza J, Baima JP, Da Silva T, Perissinotti I, Martin MDG, Goncalves M, Fortini I, Smid J, Adoni T, Lucatto L, Nitrini R, Gomes H, Castro LH (2020) Clinical, cerebrospinal fluid and neuroimaging findings in COVID-19 encephalopathy: a case series. medRxiv:2020.2008.2028.20181883. doi:https://doi.org/10.1101/2020.08.28.20181883 de Oliveira FAA, Palmeira DCC, Rocha-Filho PAS (2020) Headache and pleocytosis in CSF associated with COVID-19: case report. Neurol Sci 41(11):3021–3022. https://doi.org/10.1007/s10072-020-04694-x Hanley B, Naresh KN, Roufosse C, Nicholson AG, Weir J, Cooke GS, Thursz M, Manousou P et al (2020) Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study. Lancet Microbe 1(6):e245–e253. https://doi.org/10.1016/s2666-5247(20)30115-4 Grozdanov V, Bliederhaeuser C, Ruf WP, Roth V, Fundel-Clemens K, Zondler L, Brenner D, Martin-Villalba A et al (2014) Inflammatory dysregulation of blood monocytes in Parkinson’s disease patients. Acta Neuropathol 128(5):651–663. https://doi.org/10.1007/s00401-014-1345-4 Sawada M, Imamura K, Nagatsu T (2006) Role of cytokines in inflammatory process in Parkinson’s disease. J Neural Transm Suppl 70:373–381. https://doi.org/10.1007/978-3-211-45295-0_57 Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A, Schwartz S, Albasset S et al (2019) NLRP3 inflammasome activation drives tau pathology. Nature 575(7784):669–673. https://doi.org/10.1038/s41586-019-1769-z Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, Griep A, Axt D et al (2013) NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice. Nature 493(7434):674–678. https://doi.org/10.1038/nature11729 Togo T, Akiyama H, Iseki E, Kondo H, Ikeda K, Kato M, Oda T, Tsuchiya K et al (2002) Occurrence of T cells in the brain of Alzheimer’s disease and other neurological diseases. J Neuroimmunol 124(1-2):83–92. https://doi.org/10.1016/s0165-5728(01)00496-9 Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, Kneen R, Defres S et al (2020) Neurological associations of COVID-19. Lancet Neurol 19(9):767–783. https://doi.org/10.1016/S1474-4422(20)30221-0 Park J-H, Hong J-H, Lee S-W, Ji HD, Jung J-A, Yoon K-W, Lee J-I, Won KS et al (2019) The effect of chronic cerebral hypoperfusion on the pathology of Alzheimer’s disease: a positron emission tomography study in rats. Sci Rep 9(1):14102. https://doi.org/10.1038/s41598-019-50681-4 Zlokovic BV (2011) Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders. Nat Rev Neurosci 12(12):723–738. https://doi.org/10.1038/nrn3114 van der Lelie D, Taghavi S (2020) COVID-19 and the gut microbiome: more than a gut feeling. mSystems 5(4):e00453–e00420. https://doi.org/10.1128/mSystems.00453-20 Tikellis C, Thomas MC (2012) Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease. Int J Pept 2012:256294. https://doi.org/10.1155/2012/256294 Ni W, Yang X, Yang D, Bao J, Li R, Xiao Y, Hou C, Wang H et al (2020) Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care 24(1):422. https://doi.org/10.1186/s13054-020-03120-0 South AM, Brady TM, Flynn JT (2020) ACE2 (angiotensin-converting enzyme 2), COVID-19, and ACE inhibitor and Ang II (angiotensin II) receptor blocker use during the pandemic. Hypertension 76(1):16–22. https://doi.org/10.1161/HYPERTENSIONAHA.120.15291 Suresh Kumar VC, Mukherjee S, Harne PS, Subedi A, Ganapathy MK, Patthipati VS, Sapkota B (2020) Novelty in the gut: a systematic review and meta-analysis of the gastrointestinal manifestations of COVID-19. BMJ Open Gastroenterol 7(1):e000417. https://doi.org/10.1136/bmjgast-2020-000417 Parasa S, Desai M, Thoguluva Chandrasekar V, Patel HK, Kennedy KF, Roesch T, Spadaccini M, Colombo M et al (2020) Prevalence of gastrointestinal symptoms and fecal viral shedding in patients with coronavirus disease 2019: a systematic review and meta-analysis. JAMA Netw Open 3(6):e2011335. https://doi.org/10.1001/jamanetworkopen.2020.11335 Gu S, Chen Y, Wu Z, Chen Y, Gao H, Lv L, Guo F, Zhang X et al (2020) Alterations of the gut microbiota in patients with COVID-19 or H1N1 influenza. Clin Infect Dis. https://doi.org/10.1093/cid/ciaa709 Lippi A, Domingues R, Setz C, Outeiro TF, Krisko A (2020) SARS-CoV-2: at the crossroad between aging and neurodegeneration. Mov Disord 35(5):716–720. https://doi.org/10.1002/mds.28084 Chan C-P, Siu K-L, Chin K-T, Yuen K-Y, Zheng B, Jin D-Y (2006) Modulation of the unfolded protein response by the severe acute respiratory syndrome coronavirus spike protein. J Virol 80(18):9279–9287. https://doi.org/10.1128/jvi.00659-06 Krisko A, Radman M (2019) Protein damage, ageing and age-related diseases. Open Biol 9(3):180249. https://doi.org/10.1098/rsob.180249 Miller AH, Haroon E, Raison CL, Felger JC (2013) Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress Anxiety 30(4):297–306. https://doi.org/10.1002/da.22084 Sainz B Jr, Mossel EC, Peters CJ, Garry RF (2004) Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV). Virology 329(1):11–17. https://doi.org/10.1016/j.virol.2004.08.011 Scheper W, Hoozemans JJM (2015) The unfolded protein response in neurodegenerative diseases: a neuropathological perspective. Acta Neuropathol 130(3):315–331. https://doi.org/10.1007/s00401-015-1462-8 Williams FM, Freydin M, Mangino M, Couvreur S, Visconti A, Bowyer RC, Le Roy CI, Falchi M, Sudre C, Davies R, Hammond C, Menni C, Steves C, Spector T (2020) Self-reported symptoms of COVID-19 including symptoms most predictive of SARS-CoV-2 infection, are heritable. medRxiv 2020.2004.2022.20072124. doi:https://doi.org/10.1101/2020.04.22.20072124 Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F (2018) Oxidative stress and the amyloid beta peptide in Alzheimer’s disease. Redox Biol 14:450–464. https://doi.org/10.1016/j.redox.2017.10.014 Atkins JL, Masoli JA, Delgado J, Pilling LC, Kuo C-LC, Kuchel G, Melzer D (2020) Preexisting comorbidities predicting severe COVID-19 in older adults in the UK Biobank Community Cohort. medRxiv 2020.2005.2006.20092700. doi:https://doi.org/10.1101/2020.05.06.20092700 Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA et al (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. Jama 278(16):1349–1356 Jivanji CJ, Asrani VM, Windsor JA, Petrov MS (2017) New-onset diabetes after acute and critical illness: a systematic review. Mayo Clin Proc 92(5):762–773. https://doi.org/10.1016/j.mayocp.2016.12.020 Kuo CL, Pilling LC, Atkins JL, Masoli JAH, Delgado J, Kuchel GA, Melzer D (2020) APOE e4 genotype predicts severe COVID-19 in the UK Biobank community cohort. J Gerontol A Biol Sci Med Sci. https://doi.org/10.1093/gerona/glaa131 Yang JK, Lin SS, Ji XJ, Guo LM (2010) Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol 47(3):193–199. https://doi.org/10.1007/s00592-009-0109-4 Kehoe PG, Wong S, Al Mulhim N, Palmer LE, Miners JS (2016) Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology. Alzheimers Res Ther 8(1):50. https://doi.org/10.1186/s13195-016-0217-7 Jiang T, Zhang YD, Zhou JS, Zhu XC, Tian YY, Zhao HD, Lu H, Gao Q et al (2016) Angiotensin-(1-7) is reduced and inversely correlates with tau hyperphosphorylation in animal models of Alzheimer’s disease. Mol Neurobiol 53(4):2489–2497. https://doi.org/10.1007/s12035-015-9260-9 Fekih-Mrissa N, Bedoui I, Sayeh A, Derbali H, Mrad M, Mrissa R, Nsiri B (2017) Association between an angiotensin-converting enzyme gene polymorphism and Alzheimer’s disease in a Tunisian population. Ann General Psychiatry 16:41. https://doi.org/10.1186/s12991-017-0164-0 Yan Y-Q, Fang Y, Zheng R, Pu J-L, Zhang B-R (2020) NLRP3 Inflammasomes in Parkinson’s disease and their regulation by Parkin. Neuroscience 446:323–334. https://doi.org/10.1016/j.neuroscience.2020.08.004 Corrêa DG, de Souza Lima FC, da Cruz BD, Coutinho AC, Hygino da Cruz LC (2020) COVID-19 associated with encephalomyeloradiculitis and positive anti-aquaporin-4 antibodies: cause or coincidence? Mult Scler J. https://doi.org/10.1177/1352458520949988 Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong J-C, Turner AJ, Raizada MK, Grant MB et al (2020) Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system. Circ Res 126(10):1456–1474. https://doi.org/10.1161/CIRCRESAHA.120.317015 Inoue Y, Tanaka N, Tanaka Y, Inoue S, Morita K, Zhuang M, Hattori T, Sugamura K (2007) Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted. J Virol 81(16):8722–8729. https://doi.org/10.1128/jvi.00253-07 Mao XY, Jin WL (2020) The COVID-19 pandemic: consideration for brain infection. Neuroscience 437:130–131. https://doi.org/10.1016/j.neuroscience.2020.04.044 Beach SR, Praschan NC, Hogan C, Dotson S, Merideth F, Kontos N, Fricchione GL, Smith FA (2020) Delirium in COVID-19: a case series and exploration of potential mechanisms for central nervous system involvement. Gen Hosp Psychiatry 65:47–53. https://doi.org/10.1016/j.genhosppsych.2020.05.008 Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA et al (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet 395(10234):1417–1418. https://doi.org/10.1016/S0140-6736(20)30937-5 Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, Ueno M, Sakata H et al (2020) A first case of meningitis/encephalitis associated with SARS-coronavirus-2. Int J Infect Dis 94:55–58. https://doi.org/10.1016/j.ijid.2020.03.062 Edén A, Kanberg N, Gostner J, Fuchs D, Hagberg L, Andersson L-M, Lindh M, Price RW, Zetterberg H, Gisslén M (2020) CSF biomarkers in patients with COVID-19 and neurological symptoms. A case series https://doi.org/10.1212/WNL.0000000000010977 Bostancıklıoğlu M (2020) SARS-CoV2 entry and spread in the lymphatic drainage system of the brain. Brain Behav Immun 87:122–123. https://doi.org/10.1016/j.bbi.2020.04.080 Bagheri SHR, Asghari AM, Farhadi M, Shamshiri AR, Kabir A, Kamrava SK, Jalessi M, Mohebbi A, Alizadeh R, Honarmand AA, Ghalehbaghi B, Salimi A (2020) Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak. medRxiv:2020.2003.2023.20041889. doi:https://doi.org/10.1101/2020.03.23.20041889 Eliezer M, Hamel A-L, Houdart E, Herman P, Housset J, Jourdaine C, Eloit C, Verillaud B et al (2020) Loss of smell in COVID-19 patients: MRI data reveals a transient edema of the olfactory clefts. Neurology. https://doi.org/10.1212/wnl.0000000000010806 Chen R, Wang K, Yu J, Chen Z, Wen C, Xu Z (2020) The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in human and mouse brain. bioRxiv:2020.2004.2007.030650. doi:https://doi.org/10.1101/2020.04.07.030650 Shiers S, Ray PR, Wangzhou A, Tatsui CE, Rhines L, Li Y, Uhelski ML, Dougherty PM, Price TJ (2020) ACE2 expression in human dorsal root ganglion sensory neurons: implications for SARS-CoV-2 virus-induced neurological effects. bioRxiv:2020.2005.2028.122374. doi:https://doi.org/10.1101/2020.05.28.122374 Costello F, Dalakas MC (2020) Cranial neuropathies and COVID-19: neurotropism and autoimmunity. Neurology. https://doi.org/10.1212/WNL.0000000000009921 Esposito G, Pesce M, Seguella L, Sanseverino W, Lu J, Sarnelli G (2020) Can the enteric nervous system be an alternative entrance door in SARS-CoV2 neuroinvasion? Brain Behav Immun 87:93–94. https://doi.org/10.1016/j.bbi.2020.04.060 Rietdijk CD, Perez-Pardo P, Garssen J, van Wezel RJ, Kraneveld AD (2017) Exploring Braak’s hypothesis of Parkinson’s disease. Front Neurol 8:37. https://doi.org/10.3389/fneur.2017.00037 Paniz-Mondolfi A, Bryce C, Grimes Z, Gordon RE, Reidy J, Lednicky J, Sordillo EM, Fowkes M (2020) Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol 92(7):699–702. https://doi.org/10.1002/jmv.25915 Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S (2008) Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol 82(15):7264–7275. https://doi.org/10.1128/jvi.00737-08 Ye M, Ren Y, Lv T (2020) Encephalitis as a clinical manifestation of COVID-19. Brain Behav Immun. https://doi.org/10.1016/j.bbi.2020.04.017 Duong L, Xu P, Liu A (2020) Meningoencephalitis without respiratory failure in a young female patient with COVID-19 infection in Downtown Los Angeles, early April 2020. Brain Behav Immun 87:33. https://doi.org/10.1016/j.bbi.2020.04.024 Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497–506. https://doi.org/10.1016/s0140-6736(20)30183-5 Benameur K, Agarwal A, Auld S, Butters M, Webster A, Ozturk T, Howell JC, Bassit L et al (2020) Encephalopathy and encephalitis associated with cerebrospinal fluid cytokine alterations and coronavirus disease, Atlanta, Georgia, USA, 2020. Emerg Infect Dis J 26(9):2016–2021. https://doi.org/10.3201/eid2609.202122 Yarlagadda A, Alfson E, Clayton AH (2009) The blood brain barrier and the role of cytokines in neuropsychiatry. Psychiatry (Edgmont) 6(11):18–22 Dufek M, Rektorova I, Thon V, Lokaj J, Rektor I (2015) Interleukin-6 may contribute to mortality in Parkinson’s disease patients: a 4-year prospective study. Parkinson Disease 2015:898192. https://doi.org/10.1155/2015/898192 Lindlau A, Widmann CN, Putensen C, Jessen F, Semmler A, Heneka MT (2015) Predictors of hippocampal atrophy in critically ill patients. Eur J Neurol 22(2):410–415. https://doi.org/10.1111/ene.12443 Heneka MT, Golenbock D, Latz E, Morgan D, Brown R (2020) Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther 12(1):69. https://doi.org/10.1186/s13195-020-00640-3 Domingues C, da Cruz ESOAB, Henriques AG (2017) Impact of cytokines and chemokines on Alzheimer’s disease neuropathological hallmarks. Curr Alzheimer Res 14(8):870–882. https://doi.org/10.2174/1567205014666170317113606 Roy ER, Wang B, Wan YW, Chiu G, Cole A, Yin Z, Propson NE, Xu Y et al (2020) Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease. J Clin Invest 130(4):1912–1930. https://doi.org/10.1172/jci133737 Jones HD, Crother TR, Gonzalez-Villalobos RA, Jupelli M, Chen S, Dagvadorj J, Arditi M, Shimada K (2014) The NLRP3 inflammasome is required for the development of hypoxemia in LPS/mechanical ventilation acute lung injury. Am J Respir Cell Mol Biol 50(2):270–280. https://doi.org/10.1165/rcmb.2013-0087OC Palao M, Fernández-Díaz E, Gracia-Gil J, Romero-Sánchez CM, Díaz-Maroto I, Segura T (2020) Multiple sclerosis following SARS-CoV-2 infection. Mult Scler Relat Disord 45:102377. https://doi.org/10.1016/j.msard.2020.102377 Fazzini E, Fleming J, Fahn S (1992) Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson’s disease. Mov Disord 7(2):153–158. https://doi.org/10.1002/mds.870070210 Desforges M, Le Coupanec A, Dubeau P, Bourgouin A, Lajoie L, Dubé M, Talbot PJ (2019) Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses 12(1). https://doi.org/10.3390/v12010014 Merad M, Martin JC (2020) Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol 20(6):355–362. https://doi.org/10.1038/s41577-020-0331-4 Sevenich L (2018) Brain-resident microglia and blood-borne macrophages orchestrate central nervous system inflammation in neurodegenerative disorders and brain cancer. Front Immunol 9:697. https://doi.org/10.3389/fimmu.2018.00697 Desforges M, Miletti TC, Gagnon M, Talbot PJ (2007) Activation of human monocytes after infection by human coronavirus 229E. Virus Res 130(1-2):228–240. https://doi.org/10.1016/j.virusres.2007.06.016 Le Bert N, Tan AT, Kunasegaran K, Tham CYL, Hafezi M, Chia A, Chng MHY, Lin M et al (2020) SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature 584(7821):457–462. https://doi.org/10.1038/s41586-020-2550-z Swadling L, Maini MK (2020) T cells in COVID-19—united in diversity. Nat Immunol. https://doi.org/10.1038/s41590-020-0798-y Brochard V, Combadière B, Prigent A, Laouar Y, Perrin A, Beray-Berthat V, Bonduelle O, Alvarez-Fischer D et al (2009) Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest 119(1):182–192. https://doi.org/10.1172/jci36470 Zheng Y, Liu X, Le W, Xie L, Li H, Wen W, Wang S, Ma S et al (2020) A human circulating immune cell landscape in aging and COVID-19. Protein Cell 11(10):740–770. https://doi.org/10.1007/s13238-020-00762-2 Dolatshahi M, Pourmirbabaei S, Kamalian A, Ashraf-Ganjouei A, Yaseri M, Aarabi MH (2018) Longitudinal alterations of alpha-synuclein, amyloid beta, total, and phosphorylated tau in cerebrospinal fluid and correlations between their changes in Parkinson’s disease. Front Neurol 9:560 Shi CS, Qi HY, Boularan C, Huang NN, Abu-Asab M, Shelhamer JH, Kehrl JH (2014) SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome. J Immunol 193(6):3080–3089. https://doi.org/10.4049/jimmunol.1303196 Ye Z, Wong CK, Li P, Xie Y (2008) A SARS-CoV protein, ORF-6, induces caspase-3 mediated, ER stress and JNK-dependent apoptosis. Biochim Biophys Acta 1780(12):1383–1387. https://doi.org/10.1016/j.bbagen.2008.07.009 Aoe T (2020) Pathological aspects of COVID-19 as a conformational disease and the use of pharmacological chaperones as a potential therapeutic strategy. Front Pharmacol 11:1095. https://doi.org/10.3389/fphar.2020.01095 Sureda A, Alizadeh J, Nabavi SF, Berindan-Neagoe I, Cismaru CA, Jeandet P, Łos MJ, Clementi E et al (2020) Endoplasmic reticulum as a potential therapeutic target for COVID-19 infection management? Eur J Pharmacol 882:173288. https://doi.org/10.1016/j.ejphar.2020.173288 Wang Y, Xu E, Musich PR, Lin F (2019) Mitochondrial dysfunction in neurodegenerative diseases and the potential countermeasure. CNS Neurosci Ther 25(7):816–824. https://doi.org/10.1111/cns.13116 Zhang H, Liao YS, Gong J, Liu J, Xia X, Zhang H (2020) Clinical characteristics of coronavirus disease (COVID-19) patients with gastrointestinal symptoms: a report of 164 cases. Dig Liver Dis. https://doi.org/10.1016/j.dld.2020.04.034 Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, Wan Y, Chung A et al (2020) Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. https://doi.org/10.1053/j.gastro.2020.05.048 Ambrosini YM, Borcherding D, Kanthasamy A, Kim HJ, Willette AA, Jergens A, Allenspach K, Mochel JP (2019) The gut-brain axis in neurodegenerative diseases and relevance of the canine model: a review. Front Aging Neurosci 11:130. https://doi.org/10.3389/fnagi.2019.00130 Dhar D, Mohanty A (2020) Gut microbiota and Covid-19-possible link and implications. Virus Res 285:198018. https://doi.org/10.1016/j.virusres.2020.198018 Abiodun OA, Ola MS (2020) Role of brain renin angiotensin system in neurodegeneration: An update. Saudi J Biol Sci 27(3):905–912. https://doi.org/10.1016/j.sjbs.2020.01.026 Nataf S (2020) An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID-19. J Med Virol. https://doi.org/10.1002/jmv.25826 Benetti E, Tita R, Spiga O, Ciolfi A, Birolo G, Bruselles A, Doddato G, Giliberti A et al (2020) ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population. Eur J Hum Genet. https://doi.org/10.1038/s41431-020-0691-z Devaux CA, Rolain J-M, Raoult D (2020) ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome. J Microbiol Immunol Infect 53(3):425–435. https://doi.org/10.1016/j.jmii.2020.04.015 Lin JJ, Yueh KC, Chang DC, Lin SZ (2002) Association between genetic polymorphism of angiotensin-converting enzyme gene and Parkinson’s disease. J Neurol Sci 199(1-2):25–29. https://doi.org/10.1016/s0022-510x(02)00081-3 Kaur P, Muthuraman A, Kaur M (2015) The implications of angiotensin-converting enzymes and their modulators in neurodegenerative disorders: current and future perspectives. ACS Chem Neurosci 6(4):508–521. https://doi.org/10.1021/cn500363g Sierra-Fonseca JA, Gosselink KL (2018) Tauopathy and neurodegeneration: a role for stress. Neurobiol Stress 9:105–112. https://doi.org/10.1016/j.ynstr.2018.08.009 Ibrahimagic OC, Jakubovic AC, Smajlovic D, Dostovic Z, Kunic S, Iljazovic A (2016) Psychological stress and changes of hypothalamic-pituitary-adrenal axis in patients with “de novo” Parkinson’s disease. Mediev Archaeol 70(6):445–448. https://doi.org/10.5455/medarh.2016.70.445-448 Agarwal S, Agarwal SK (2020) Endocrine changes in SARS-CoV-2 patients and lessons from SARS-CoV. Postgrad Med J 96(1137):412–416. https://doi.org/10.1136/postgradmedj-2020-137934 Oudit GY, Kassiri Z, Jiang C, Liu PP, Poutanen SM, Penninger JM, Butany J (2009) SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Investig 39(7):618–625. https://doi.org/10.1111/j.1365-2362.2009.02153.x Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, Huan Y, Yang P et al (2005) A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury. Nat Med 11(8):875–879. https://doi.org/10.1038/nm1267 Wang LA, de Kloet AD, Smeltzer MD, Cahill KM, Hiller H, Bruce EB, Pioquinto DJ, Ludin JA et al (2018) Coupling corticotropin-releasing-hormone and angiotensin converting enzyme 2 dampens stress responsiveness in male mice. Neuropharmacology 133:85–93. https://doi.org/10.1016/j.neuropharm.2018.01.025 Steenblock C, Todorov V, Kanczkowski W, Eisenhofer G, Schedl A, Wong M-L, Licinio J, Bauer M et al (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis. Mol Psychiatry. https://doi.org/10.1038/s41380-020-0758-9 Leow MK, Kwek DS, Ng AW, Ong KC, Kaw GJ, Lee LS (2005) Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). Clin Endocrinol 63(2):197–202. https://doi.org/10.1111/j.1365-2265.2005.02325.x Morris G, Anderson G, Maes M (2017) Hypothalamic-pituitary-adrenal hypofunction in myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) as a consequence of activated immune-inflammatory and oxidative and nitrosative pathways. Mol Neurobiol 54(9):6806–6819. https://doi.org/10.1007/s12035-016-0170-2 Chen W (2020) A potential treatment of COVID-19 with TGF-β blockade. Int J Biol Sci 16(11):1954–1955. https://doi.org/10.7150/ijbs.46891 Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, Alvarado-Arnez LE, Bonilla-Aldana DK et al (2020) Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis 34:101623. https://doi.org/10.1016/j.tmaid.2020.101623 Sasannejad C, Ely EW, Lahiri S (2019) Long-term cognitive impairment after acute respiratory distress syndrome: a review of clinical impact and pathophysiological mechanisms. Crit Care 23(1):352. https://doi.org/10.1186/s13054-019-2626-z Kanberg N, Ashton NJ, Andersson LM, Yilmaz A, Lindh M, Nilsson S, Price RW, Blennow K et al (2020) Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19. Neurology. https://doi.org/10.1212/wnl.0000000000010111 Fries M, Bickenbach J, Henzler D, Beckers S, Dembinski R, Sellhaus B, Rossaint R, Kuhlen R (2005) S-100 protein and neurohistopathologic changes in a porcine model of acute lung injury. Anesthesiology 102(4):761–767. https://doi.org/10.1097/00000542-200504000-00011 Erickson MA, Banks WA (2013) Blood-brain barrier dysfunction as a cause and consequence of Alzheimer’s disease. J Cereb Blood Flow Metab 33(10):1500–1513. https://doi.org/10.1038/jcbfm.2013.135 Sonneville R, Verdonk F, Rauturier C, Klein IF, Wolff M, Annane D, Chretien F, Sharshar T (2013) Understanding brain dysfunction in sepsis. Ann Intensive Care 3(1):15. https://doi.org/10.1186/2110-5820-3-15 Taccone FS, Castanares-Zapatero D, Peres-Bota D, Vincent JL, Berre J, Melot C (2010) Cerebral autoregulation is influenced by carbon dioxide levels in patients with septic shock. Neurocrit Care 12(1):35–42. https://doi.org/10.1007/s12028-009-9289-6 Hess DC, Eldahshan W, Rutkowski E (2020) COVID-19-related stroke. Transl Stroke Res 11(3):322–325. https://doi.org/10.1007/s12975-020-00818-9 Klok FA, Kruip M, van der Meer NJM, Arbous MS, Gommers D, Kant KM, Kaptein FHJ, van Paassen J et al (2020) Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. Thromb Res 191:148–150. https://doi.org/10.1016/j.thromres.2020.04.041 Xu P, Sriramula S, Lazartigues E (2011) ACE2/ANG-(1–7)/Mas pathway in the brain: the axis of good. Am J Phys Regul Integr Comp Phys 300(4):R804–R817. https://doi.org/10.1152/ajpregu.00222.2010 Scudamore O, Ciossek T (2018) Increased oxidative stress exacerbates α-synuclein aggregation in vivo. J Neuropathol Exp Neurol 77(6):443–453. https://doi.org/10.1093/jnen/nly024 Goldstein MR, Poland GA, Graeber WC (2020) Does apolipoprotein E genotype predict COVID-19 severity? QJM: an International Journal of Medicine. https://doi.org/10.1093/qjmed/hcaa142 Wang H, Yuan Z, Pavel MA, Hansen SB (2020) The role of high cholesterol in age-related COVID19 lethality. bioRxiv. https://doi.org/10.1101/2020.05.09.086249 Riedel BC, Thompson PM, Brinton RD (2016) Age, APOE and sex: triad of risk of Alzheimer’s disease. J Steroid Biochem Mol Biol 160:134–147. https://doi.org/10.1016/j.jsbmb.2016.03.012 Wu Q, Zhou L, Sun X, Yan Z, Hu C, Wu J, Xu L, Li X et al (2017) Altered lipid metabolism in recovered SARS patients twelve years after infection. Sci Rep 7(1):9110. https://doi.org/10.1038/s41598-017-09536-z Huang M, Parker AM, Bienvenu OJ, Dinglas VD, Colantuoni E, Hopkins RO, Needham DM (2016) psychiatric symptoms in acute respiratory distress syndrome survivors: a 1-year national multicenter study. Crit Care Med 44(5):954–965. https://doi.org/10.1097/ccm.0000000000001621 Higgs S, Spetter MS (2018) Cognitive Control of eating: the role of memory in appetite and weight gain. Curr Obes Rep 7(1):50–59. https://doi.org/10.1007/s13679-018-0296-9 Cai H, Cong WN, Ji S, Rothman S, Maudsley S, Martin B (2012) Metabolic dysfunction in Alzheimer’s disease and related neurodegenerative disorders. Curr Alzheimer Res 9(1):5–17. https://doi.org/10.2174/156720512799015064 Kang Z, Luo S, Gui Y, Zhou H, Zhang Z, Tian C, Zhou Q, Wang Q et al (2020) Obesity is a potential risk factor contributing to clinical manifestations of COVID-19. Int J Obes. https://doi.org/10.1038/s41366-020-00677-2 Cao X, Yin R, Albrecht H, Fan D, Tan W (2020) Cholesterol: a new game player accelerating vasculopathy caused by SARS-CoV-2? Am J Physiol Endocrinol Metab 319(1):E197–e202. https://doi.org/10.1152/ajpendo.00255.2020 Hribar CA, Cobbold PH, Church FC (2020) Potential role of vitamin D in the elderly to resist COVID-19 and to slow progression of Parkinson’s disease. Brain Sci 10(5):284. https://doi.org/10.3390/brainsci10050284